ClearPoint Neuro Financials

ClearPoint Neuro Inc

CLPTNASDAQ

Trade with Public

$13.16

0.292.21%

At close: Aug 4, 5:00 PM EST

$13.15

0.282.14%

Pre-Market: 4:14 AM EST

Earnings: Q2 2026 Earnings were released on Mon Aug 3rd, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 3 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

ClearPoint Neuro Financials

ClearPoint Neuro (CLPT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
ClearPoint Neuro Lowers FY2026 Sales Guidance from $52.000M-$56.000M to $48.000M-$52.000M vs $53.133M Est

ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $52.000 million-$56.000 million to $48.000 million-$52.000 million vs $53.133 million estimate.

Benzinga Newsdesk

PRO
ClearPoint Neuro Q2 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.880M Miss $12.733M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 80.95 percent decrease over losses of $(0.21) per share

Benzinga Newsdesk

PRO
ClearPoint Neuro Affirms FY2026 Sales Guidance of $52.000M-$56.000M vs $52.800M Est

Benzinga Newsdesk

PRO
ClearPoint Neuro Q1 EPS $(0.32) Misses $(0.26) Estimate, Sales $12.128M Beat $12.000M Estimate

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
ClearPoint Neuro Q4 EPS $(0.23) Misses $(0.20) Estimate, Sales $10.400M Beat $10.050M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.20) by 15 percent. This is a 15 percent decrease over losses of $(0.20) per share from the

Benzinga Newsdesk

Earnings: Q2 2026 Earnings were released on Mon Aug 3rd, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 3 days ago

Click to view the webcast

Benzinga

Benzinga

ClearPoint Neuro Inc

ClearPoint Neuro Financials

Earnings & Guidance News

PROClearPoint Neuro Lowers FY2026 Sales Guidance from $52.000M-$56.000M to $48.000M-$52.000M vs $53.133M Est

PROClearPoint Neuro Q2 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.880M Miss $12.733M Estimate

PROClearPoint Neuro Affirms FY2026 Sales Guidance of $52.000M-$56.000M vs $52.800M Est

PROClearPoint Neuro Q1 EPS $(0.32) Misses $(0.26) Estimate, Sales $12.128M Beat $12.000M Estimate

Earnings Scheduled For May 13, 2026

PROClearPoint Neuro Q4 EPS $(0.23) Misses $(0.20) Estimate, Sales $10.400M Beat $10.050M Estimate

PRO
ClearPoint Neuro Lowers FY2026 Sales Guidance from $52.000M-$56.000M to $48.000M-$52.000M vs $53.133M Est

PRO
ClearPoint Neuro Q2 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.880M Miss $12.733M Estimate

PRO
ClearPoint Neuro Affirms FY2026 Sales Guidance of $52.000M-$56.000M vs $52.800M Est

PRO
ClearPoint Neuro Q1 EPS $(0.32) Misses $(0.26) Estimate, Sales $12.128M Beat $12.000M Estimate

PRO
ClearPoint Neuro Q4 EPS $(0.23) Misses $(0.20) Estimate, Sales $10.400M Beat $10.050M Estimate